Donor-gifted allograft urolithiasis: Early percutaneous management

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 台中附設醫院 > 期刊論文 > Item 310903500/29306

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/29306

题名:	Donor-gifted allograft urolithiasis: Early percutaneous management
作者:	Lu, HF;Shekarriz, B;Stoller, ML
贡献者:	附設醫院泌尿部;Univ Calif San Francisco, Sch Med, Dept Urol, San Francisco, CA 94143 USA;China Med Coll Hosp, Dept Urol, Taichung, Taiwan
日期:	2002
上传时间:	2010-09-24 14:31:36 (UTC+8)
出版者:	ELSEVIER SCIENCE INC
摘要:	A mixture of poly(ethylene-co-vinyl alcohol) (EVAL),dimethylsulfoxide(DMSO) and doxorubicin was precipitated from the 1-octanol to form membranes with particles bonded to each other. The drug release profile from the EVAL membrane was investigated for 96h. Results showed that the release behavior of doxorubicin was increasing with time and a two-step release behavior, a fast and a slow releasing pattern was revealed. It was also found that the number of cancer cells could be significantly decreased by released doxorubicin from the EVAL membrane. It is concluded that the EVAL copolymer could be an ideal encapsulating material for drugs to treat chronic diseases. (C) 2002 Elsevier Science B.V. All rights reserved.
關聯:	UROLOGY 59(1):25-27
显示于类别:	[台中附設醫院] 期刊論文

文件中的档案:

没有与此文件相关的档案.

在CMUR中所有的数据项都受到原著作权保护.

TAIR相关文章